The induction of the initiating phase of skin carcinogenesis in the mouse by oral administration of 9:10-dimethyl-1:2-benzanthracene, 20-methyl-cholanthrene, 3:4-benspyrene, and 1:2:5:6-dibenzanthracene.
D000284:Administration, Oral; D000818:Animals; D001551:Benz(a)Anthracenes / Q000009:adverse effects*; D063646:Carcinogenesis; D008748:Methylcholanthrene; D051379:Mice; D009374:Neoplasms, Experimental; D012878:Skin Neoplasms
D001551:Benz(a)Anthracenes; C016365:dibenzanthracenes; C053714:cholanthrene; D008748:Methylcholanthrene; C030935:benz(a)anthracene
BENZANTHRACENES/injurious effects; METHYLCHOLANTHRENE; SKIN NEOPLASMS/experimental
Cancer Res. 1956 Aug;16(7):675-80
13356294